Challenge
A cutting-edge $10B biopharma with a rapidly growing pipeline struggled with its full-service outsourcing (FSO) partners- particularly with biometry- data management, stats/ programming and biostats; performance and cost.
Approach
Helped to evaluate multiple internal vs. FSO vs. FSP sourcing models and provided extensive benchmarks and datapoints to help support an aligned vision for a 'goldilocks' solution- an FSP partnership that entailed low-cost country staff augmentation, with sponsor SOPs and requirements. Helped to identify the low-cost-country foundation, build this capability and fully transition to this model.
Impact
Helped to identify the right low-cost country strategy, staffing and org design. While the initial investment outlay was high, this strategy ultimately realized significant enhancements in delivery with a 40% cost reduction against the prior FSO model.
